A Phase Ii Trial of Gefitinib in Combination with Bevacizumab As First-Line Therapy for Advanced Non-Small-Cell Lung Cancer with Activating Egfr Gene Mutations: Olcsg 1001

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 25; p. iv452
Main Authors	Nogami, N., Ichihara, E., Kozuki, T., Kubo, T., Kishino, D., Kuyama, S., Bessho, A., Fujii, M., Takigawa, N., Chikamori, K., Aoe, K., Nagata, T., Fujimoto, N., Hosokawa, S., Harita, S., Kamei, H., Ueoka, H., Hotta, K., Tanimoto, M., Kiura, K.
Format	Journal Article
Language	English
Published	01.09.2014
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1093/annonc/mdu349.64